BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27077911)

  • 1. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
    Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
    PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq™ panel and Ion Torrent PGM sequencing.
    Cao YY; Qu YJ; Song F; Zhang T; Bai JL; Jin YW; Wang H
    Mol Genet Metab; 2014 Dec; 113(4):261-6. PubMed ID: 25456745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Druggable' alterations detected by Ion Torrent in metastatic colorectal cancer patients.
    Fang W; Radovich M; Zheng Y; Fu CY; Zhao P; Mao C; Zheng Y; Zheng S
    Oncol Lett; 2014 Jun; 7(6):1761-1766. PubMed ID: 24932229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
    Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
    Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
    J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing in synovial sarcoma reveals novel gene mutations.
    Vlenterie M; Hillebrandt-Roeffen MH; Flucke UE; Groenen PJ; Tops BB; Kamping EJ; Pfundt R; de Bruijn DR; Geurts van Kessel AH; van Krieken HJ; van der Graaf WT; Versleijen-Jonkers YM
    Oncotarget; 2015 Oct; 6(33):34680-90. PubMed ID: 26415226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.
    Xu Z; Huo X; Ye H; Tang C; Nandakumar V; Lou F; Zhang D; Dong H; Sun H; Jiang S; Zhang G; Liu Z; Dong Z; Guo B; He Y; Yan C; Wang L; Su Z; Li Y; Gu D; Zhang X; Wu X; Wei X; Hong L; Zhang Y; Yang J; Gong Y; Tang C; Jones L; Huang XF; Chen SY; Chen J
    PLoS One; 2014; 9(7):e100442. PubMed ID: 25025766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing.
    Youssef O; Sarhadi V; Ehsan H; Böhling T; Carpelan-Holmström M; Koskensalo S; Puolakkainen P; Kokkola A; Knuutila S
    World J Gastroenterol; 2017 Dec; 23(47):8291-8299. PubMed ID: 29307989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot spot mutations in Finnish non-small cell lung cancers.
    Mäki-Nevala S; Sarhadi VK; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuuttila A; Knuutila S
    Lung Cancer; 2016 Sep; 99():102-10. PubMed ID: 27565922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
    Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
    Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
    Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
    Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
    Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
    Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
    Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA
    Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification by somatic mutation burden in Ewing sarcoma.
    Liu KX; Lamba N; Hwang WL; Niemierko A; DuBois SG; Haas-Kogan DA
    Cancer; 2019 Apr; 125(8):1357-1364. PubMed ID: 30602061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma.
    Mackintosh C; Ordóñez JL; García-Domínguez DJ; Sevillano V; Llombart-Bosch A; Szuhai K; Scotlandi K; Alberghini M; Sciot R; Sinnaeve F; Hogendoorn PC; Picci P; Knuutila S; Dirksen U; Debiec-Rychter M; Schaefer KL; de Álava E
    Oncogene; 2012 Mar; 31(10):1287-98. PubMed ID: 21822310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.